Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tanshinone IIA attenuates heart failure via inhibiting oxidative stress in myocardial infarction rats
Chen Rui-juan, Wenli Chen, Xiaoling Huang, et al.
Molecular Medicine Reports (2021) Vol. 23, Iss. 6
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Signaling pathways and targeted therapy for myocardial infarction
Qing Zhang, Lu Wang, Shiqi Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 468
The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms
Jie Chen, Xiao‐Hong Wei, Qian Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 1919-1955
Open Access | Times Cited: 53
The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms
Yuling Wang, Linke Jiao, Caoxia Qiang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116116-116116
Open Access | Times Cited: 28
Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
Xiaoying Yin, Xinxin Yin, Xin Pan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 33
New Insights into Mechanisms Traditional Chinese Medicine for Allergic Rhinitis by Regulating Inflammatory and Oxidative Stress Pathways
Qin Zhu, Liangzhen Xie, Wentao Li, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 97-112
Open Access | Times Cited: 11
A ROS-responsive TPP-modified tanshinone IIA micelle improves DOX-induced heart failure
Yan Zhao, Jiahua Wang, Zixu Zhang, et al.
International Journal of Pharmaceutics (2025) Vol. 672, pp. 125318-125318
Closed Access | Times Cited: 1
Natural products from traditional Chinese medicine for the prevention and treatment of heart failure: progress and perspectives
Linhao Xu, Liuying Chen, Gaoyang Gu, et al.
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 2, pp. 060-060
Open Access | Times Cited: 24
A Pharmacological Review of Tanshinones, Naturally Occurring Monomers from Salvia miltiorrhiza for the Treatment of Cardiovascular Diseases
Ye Yang, Mingyan Shao, Wenkun Cheng, et al.
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-24
Open Access | Times Cited: 16
Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?
Milton Packer
European Journal of Heart Failure (2023) Vol. 25, Iss. 12, pp. 2130-2143
Open Access | Times Cited: 16
A review on experimental surgical models and anesthetic protocols of heart failure in rats
Ahmed Farag, Ahmed S. Mandour, Hanan Hendawy, et al.
Frontiers in Veterinary Science (2023) Vol. 10
Open Access | Times Cited: 15
Novel lncRNA-miRNA-mRNA Competing Endogenous RNA Triple Networks Associated Programmed Cell Death in Heart Failure
Yu Zheng, Yingjie Zhang, Zhang Xiu, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 27
Cellular mechanisms and molecular pathways linking bitter taste receptor signalling to cardiac inflammation, oxidative stress, arrhythmia and contractile dysfunction in heart diseases
Menizibeya O. Welcome, D Dogo, Nikos E. Mastorakis
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 89-117
Open Access | Times Cited: 19
Salvia miltiorrhiza Bunge root in the treatment of myocardial fibrosis: research progress and challenges
Qianrong Li, Chunzhen Ren, Bing Jiang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Tanshinone IIA ameliorates myocardial ischemia/reperfusion injury in rats by regulation of NLRP3 inflammasome activation and Th17 cells differentiation
Dan Li, Zhihui Yang, Shan Gao, et al.
Acta Cirúrgica Brasileira (2022) Vol. 37, Iss. 7
Open Access | Times Cited: 11
Danshen-Shanzha formula for the treatment of atherosclerosis: ethnopharmacological relevance, preparation methods, chemical constituents, pharmacokinetic properties, and pharmacological effects
Qiong Xu, Zhe Yu, Meng Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Evidence and Characteristics of Traditional Chinese Medicine for Coronary Heart Disease Patients With Anxiety or Depression: A Meta-Analysis and Systematic Review
Baofu Wang, Yu Teng, Yang Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Tanshinone IIA Accomplished Protection against Radiation-Induced Cardiomyocyte Injury by Regulating the p38/p53 Pathway
Gang Wang, Li Ma, Bowen Wang, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 10
Protective effects of tanshinone IIA on Porphyromonas gingivalis-induced atherosclerosis via the downregulation of the NOX2/NOX4-ROS mediation of NF-κB signaling pathway
Xuan Yan, Yu Cai, Kang Ni, et al.
Microbes and Infection (2023) Vol. 25, Iss. 8, pp. 105177-105177
Open Access | Times Cited: 5
STS ⅡA inhibited angiogenesis of lung adenocarcinoma by activating FOXO3 to inhibit CXCL1/STAT3/VEGF pathway
Bu Wang, Fang Zou, Xin Gu, et al.
Toxicon (2024) Vol. 240, pp. 107627-107627
Closed Access | Times Cited: 1
Optimized New Shengmai Powder modulation of cAMP/Rap1A signaling pathway attenuates myocardial fibrosis in heart failure
Zeyu Zhang, Zhe Xu, Shuai Wang, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Tanshinone IIA through the PGK1/PDHK1 Pathway Affecting Macrophage Reprogramming in the Repair Process of Myocardial Infarction
Xiaogang Li, Xu Li
Cardiovascular Drugs and Therapy (2024)
Closed Access | Times Cited: 1
Ershen Zhenwu Decoction Suppresses Myocardial Fibrosis of Chronic Heart Failure with Heart–Kidney Yang Deficiency by Down-Regulating the Ras Homolog Gene Family Member A/Rho-Associated Coiled-Coil Kinases Signaling Pathway
Dan Cheng, Sheng Sheng, Jing Hu, et al.
Journal of Ethnopharmacology (2024) Vol. 340, pp. 119146-119146
Closed Access | Times Cited: 1
Mechanistic analysis of Tanshinone IIA’s regulation of the ATM/GADD45/ORC signaling pathway to reduce myocardial ischemia-reperfusion injury
Yun Sang, Jiangnan Du, Dilimulati Zulikala, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
The therapeutic effect of tanshinone IIA in mouse astrocytes after treatment with Angiostrongylus cantonensis fifth-stage larval excretory-secretory products
Kuang-Yao Chen, Yi‐Ju Chen, Chien-Ju Cheng, et al.
Journal of Microbiology Immunology and Infection (2023) Vol. 56, Iss. 4, pp. 853-862
Open Access | Times Cited: 3
Screening and identification of effective components from modified Taohong Siwu decoction for protecting H9c2 cells from damage
Yachao Wang, Huan Wang, Chang-le Shao, et al.
In Vitro Cellular & Developmental Biology - Animal (2023) Vol. 59, Iss. 5, pp. 346-355
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top